These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical experience concerning the action of a new oral antidiabetic drug: glidiazinamide]. Greco AV; Fedeli G; Ghirlanda G; Lucente M; Accietto F; Fenici R Minerva Med; 1971 Jul; 62(57):2829-39. PubMed ID: 5565179 [No Abstract] [Full Text] [Related]
3. Oral sulphonylureas in the management of diabetes. Jackson WP S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995 [No Abstract] [Full Text] [Related]
4. Glibenclamide in the management of diabetes mellitus. I. Devlin JG; Manning K; Harty J J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337 [No Abstract] [Full Text] [Related]
5. Clinical trial of glybenclamide, a hypoglycaemic agent. Walker RL Med J Aust; 1970 Nov; 2(22):1015-6. PubMed ID: 4924417 [No Abstract] [Full Text] [Related]
6. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients]. Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854 [No Abstract] [Full Text] [Related]
7. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419]. Marocco F; Patrito G Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124 [No Abstract] [Full Text] [Related]
8. [The development of sulfonylurea late resistance]. Angeli I Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930 [No Abstract] [Full Text] [Related]
9. [Currency on the knowledge of biosynthesis and insulin liberation. Clinical experience on the use of glybenclamide]. Aznar Reig A; Trujillo Rodríguez F; Algaba Moreno J Rev Iber Endocrinol; 1970; 17(99):199-240. PubMed ID: 5456328 [No Abstract] [Full Text] [Related]
10. [Oral differential therapy of diabetes mellitus]. Mehnert H Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987 [No Abstract] [Full Text] [Related]
11. [Our experience with Daonil. A new oral hypoglycemic agent]. Rodriguez-Miñon JL; Arrieta F; Herrera JL Diabete; 1970; 18(3):164-5. PubMed ID: 5472233 [No Abstract] [Full Text] [Related]
12. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus]. Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527 [No Abstract] [Full Text] [Related]
13. [Mechanism of action of oral antidiabetics]. Apelategui Arrese JM Rev Med Univ Navarra; 1972 Jun; 15(2):129-36. PubMed ID: 5048537 [No Abstract] [Full Text] [Related]
14. [Mechanism of action of oral antidiabetics]. Apelategui Arrese JM Rev Med Univ Navarra; 1971 Jun; 15(2):129-36. PubMed ID: 5162174 [No Abstract] [Full Text] [Related]
15. [Risks of severe hypoglycemia after glibenclamide (daonil or euglucan). A report of 10 cases of coma observed during a period of 6 months]. Raymond JP; Chimènes H; Klotz HP Diabete; 1971; 19(1):31-2. PubMed ID: 4999031 [No Abstract] [Full Text] [Related]
16. Clinical experience with glybenclamide in 100 non-ketotic diabetics. Sahgal VK; Ahuja MM Indian J Med Res; 1971 Feb; 59(2):251-8. PubMed ID: 4931412 [No Abstract] [Full Text] [Related]